Quality-of-life effects of prostate-specific antigen screening. (Q34294102)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22894572%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

title

Quality-of-life effects of prostate-specific antigen screening (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22894572%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22894572%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Arnauld Villers

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22894572%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Marie-Louise Essink-Bot

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22894572%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Monique Roobol

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22894572%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

5

Stefano Ciatto

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22894572%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

12

Teuvo L J Tammela

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22894572%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

15

Ida J Korfage

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22894572%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

19

Chris H Bangma

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22894572%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

6

Vera Nelen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22894572%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

4

Jonas Hugosson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22894572%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

7

Maciej Kwiatkowski

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22894572%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

11

Marco Zappa

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22894572%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

author name string

Eveline A M Heijnsdijk

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22894572%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Elisabeth M Wever

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22894572%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Alvaro Páez

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22894572%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Sue M Moss

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22894572%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Tuukka Mäkinen

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22894572%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Sigrid Carlsson

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22894572%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Suzie J Otto

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22894572%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Gerrit Draisma

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22894572%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Fritz H Schröder

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22894572%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Harry J de Koning

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22894572%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

language of work or name

English

0 references

publication date

1 August 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22894572%20AND%20SRC:MED&resulttype=core&format=json

The New England Journal of Medicine

11 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22894572%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

volume

367

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22894572%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22894572%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

page(s)

595-605

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22894572%20AND%20SRC:MED&resulttype=core&format=json

Active surveillance for prostate cancer: progress and promise

11 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4982868

Long-term survival after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4982868

Active surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4982868

Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4982868

Mortality results from the Göteborg randomised population-based prostate-cancer screening trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4982868

Quality of life three years after diagnosis of localised prostate cancer: population based cohort study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4982868

A risk-based strategy improves prostate-specific antigen-driven detection of prostate cancer.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4982868

Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4982868

Screening and prostate-cancer mortality in a randomized European study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4982868

Mortality results from a randomized prostate-cancer screening trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4982868

Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4982868

Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4982868

PSA-based screening for prostate cancer: how does it compare with other cancer screening tests?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4982868

Screening for prostate cancer: a Cochrane systematic review.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4982868

20-year outcomes following conservative management of clinically localized prostate cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4982868

The story of the European Randomized Study of Screening for Prostate Cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4982868

Effectiveness and cost-effectiveness of prognostic markers in prostate cancer.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4982868

Short-term effects of population-based screening for prostate cancer on health-related quality of life

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4982868

Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4982868

Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4982868

Prostate cancer survivors who would be eligible for active surveillance but were either treated with radiotherapy or managed expectantly: comparisons on long-term quality of life and symptom burden

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4982868

The effect of study arm on prostate cancer treatment in the large screening trial ERSPC.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4982868

Individualizing quality-of-life outcomes reporting: how localized prostate cancer treatments affect patients with different levels of baseline urinary, bowel, and sexual function

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4982868

Surveillance and deferred treatment for localized prostate cancer. Population based study in the National Prostate Cancer Register of Sweden

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4982868

Bowel, urinary, and sexual problems among long-term prostate cancer survivors: a population-based study

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4982868

Estimating lead time and overdiagnosis associated with PSA screening from prostate cancer incidence trends

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4982868

Prostate cancer diagnosis: the impact on patients' mental health.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4982868

Long-term hormone therapy and radiation is cost-effective for patients with locally advanced prostate carcinoma

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4982868

Is combined androgen blockade with bicalutamide cost-effective compared with combined androgen blockade with flutamide?

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4982868

Lifetime implications and cost-effectiveness of using finasteride to prevent prostate cancer

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4982868

The cost-effectiveness of combined androgen blockade with bicalutamide and luteinizing hormone releasing hormone agonist in men with metastatic prostate cancer

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4982868

Five-year follow-up of health-related quality of life after primary treatment of localized prostate cancer.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4982868

Utilities for prostate cancer health states in men aged 60 and older.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4982868

Cost-effectiveness analysis of bicalutamide (Casodex) for adjuvant treatment of early prostate cancer

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4982868

Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4982868

Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4982868

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4982868

Cost-effective models for flutamide for prostate carcinoma patients: are they helpful to policy makers?

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4982868

Prediction of Indolent Prostate Cancer: Validation and Updating of a Prognostic Nomogram

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4982868

Economic analysis of a phase III clinical trial evaluating the addition of total androgen suppression to radiation versus radiation alone for locally advanced prostate cancer (Radiation Therapy Oncology Group protocol 86-10)

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4982868

Test Sensitivity in the European Prostate Cancer Screening Trial: Results from Finland, Sweden, and the Netherlands

28 October 2018

1 reference

12 December 2020

Prospective validation of active surveillance in prostate cancer: the PRIAS study

1 reference

12 December 2020

1 reference

12 December 2020

Would prostate cancer detected by screening with prostate-specific antigen develop into clinical cancer if left undiagnosed? A comparison of two population-based studies in Sweden

1 reference

12 December 2020

Outcomes of men with screen-detected prostate cancer eligible for active surveillance who were managed expectantly

1 reference

12 December 2020

The excess burden of side-effects from treatment in men allocated to screening for prostate cancer. The Göteborg randomised population-based prostate cancer screening trial

1 reference

12 December 2020

Patients’ perceptions of the side-effects of prostate cancer treatment—A qualitative interview study

1 reference

12 December 2020

The impact of a breast cancer screening programme on quality-adjusted life-years

1 reference

12 December 2020

Quality of life and satisfaction with outcome among prostate-cancer survivors

1 reference

12 December 2020

Overdiagnosis of prostate carcinoma by screening: an estimate based on the results of the Florence Screening Pilot Study

1 reference

12 December 2020

Identifiers

DOI

10.1056/NEJMOA1201637

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22894572%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22894572%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22894572%20AND%20SRC:MED&resulttype=core&format=json